Prilly, Switzerland

Michael Paris

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Inventor Michael Paris: Pioneering Innovations in Cardiac Stent-Valve Technology**

Introduction

Michael Paris, based in Prilly, Switzerland, is an accomplished inventor known for his significant contributions to medical technology. With two patents to his name, Michael has been instrumental in developing innovative solutions in the field of cardiac interventions, particularly in the area of transcatheter stent-valve systems.

Latest Patents

Michael's latest patents focus on a revolutionary method and apparatus for compressing and loading stent-valves. The apparatus consists of a hollow channel designed with an interior surface that progressively compresses the stent-valve as it moves longitudinally within the channel. A threaded driver generates a longitudinal driving force through rotation, while a mover with projecting limbs transmits this driving force to the stent-valve. Additionally, the apparatus includes a removable channel extension for creating a cylindrical containment bore, enhancing its utility in medical applications.

Career Highlights

Throughout his career, Michael Paris has worked at Symetis SA, where he has dedicated his efforts to advancing cardiac device technologies. His innovative approaches have not only led to the development of patented technologies but also positioned him as a leading figure in the medical engineering community.

Collaborations

In his professional journey, Michael has collaborated with notable colleagues, including Jacques Essinger and Stephane Delaloye. These partnerships have facilitated a synergistic environment for creativity and innovation, resulting in advancements that improve patient outcomes and streamline medical procedures.

Conclusion

Michael Paris exemplifies the spirit of innovation within the medical technology industry. His patents and collaborations reflect his commitment to improving cardiac intervention techniques. As he continues to work at Symetis SA, Michael remains a valuable contributor to the evolution of stent-valve technologies, pushing boundaries to enhance patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…